EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Temporal Trends and Disparities in Mortality Associated With Type 2 Diabetes and Ischemic Heart Disease in the United States (1999−2024)

Muhammad Shaheer Bin Faheem, Syed Tawassul Hassan, Syed Atta Ur Rafe, Sivaram Neppala, Nafila Zeeshan, Akshay Kumar, Nimra Shafi, Sumaya Samadi, Yasar Sattar

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70513 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Introduction Patients with co‐existing type 2 diabetes mellitus (T2DM) and ischemic heart disease (IHD) face a higher mortality risk than those with either condition alone. We examined US mortality trends and disparities in adults with both conditions, 1999–2024. Methods CDC WONDER death certificate data were used to identify adults aged ≥ 45 years with both T2DM (ICD‐10 E11) and IHD (I20–I25) listed as underlying or contributing causes. Age‐adjusted mortality rates (AAMRs) per 100 000 were calculated, and trends were assessed with Joinpoint regression (permutation test) to estimate annual percent change (APC) and average annual percent change (AAPC). Results T2DM and IHD were co‐listed on 828 250 death certificates. The AAMR rose from 18.87 in 1999 to 37.65 in 2021 and was 32.97 in 2024 (AAPC 2.06%; 95% CI, 1.68–2.61). AAMRs increased until 2005 (APC 3.51%), declined until 2015 (APC −0.93%), surged until 2021 (APC 9.06%), and declined thereafter (APC −4.04%). AAMRs were higher in males than females (36.33 vs. 18.53) and highest among non‐Hispanic American Indian or Alaska Native adults (44.27). Age‐specific rates rose from 2.74 (45–54 years) to 149.59 (≥ 85 years). AAMRs were higher in non‐metropolitan than metropolitan areas (30.89 vs. 22.59; 1999–2020) and highest in the West (31.24) and Midwest (30.57). Conclusions AAMRs increased overall from 1999 to 2024 despite a decline after 2021, with marked demographic and geographic disparities. Targeted interventions and equitable access to cardioprotective therapies are needed for high‐risk populations.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →